2019 Q2 Form 10-Q Financial Statement

#000156459019030747 Filed on August 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2 2017 Q4
Revenue $0.00 $1.333M $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.800M $3.140M $2.510M
YoY Change -10.83% 30.29% 91.6%
% of Gross Profit
Research & Development $2.264M $4.229M $3.780M
YoY Change -46.46% 33.44% 89.95%
% of Gross Profit
Depreciation & Amortization $20.00K $10.00K $10.00K
YoY Change 100.0% -50.0% -50.0%
% of Gross Profit
Operating Expenses $5.979M $7.370M $6.289M
YoY Change -18.87% 31.98% 90.26%
Operating Profit -$5.979M -$6.036M -$6.289M
YoY Change -0.95% 8.11% 90.26%
Interest Expense $290.4K $46.46K $50.00K
YoY Change 524.95% -11.19% -121.74%
% of Operating Profit
Other Income/Expense, Net $295.3K $46.46K $53.83K
YoY Change 535.55% -26.89% -125.32%
Pretax Income -$5.680M -$5.990M -$6.240M
YoY Change -5.18% 8.51% 77.27%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.684M -$5.990M -$6.235M
YoY Change -5.11% 8.51% 77.23%
Net Earnings / Revenue -449.25%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.10 -$3.29 -$3.45
COMMON SHARES
Basic Shares Outstanding 27.34M
Diluted Shares Outstanding 27.34M

Balance Sheet

Concept 2019 Q2 2018 Q2 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $48.20M $68.80M $20.30M
YoY Change -29.94% 138.06%
Cash & Equivalents $48.16M $68.78M $20.26M
Short-Term Investments $0.00
Other Short-Term Assets $264.3K $213.5K $322.2K
YoY Change 23.82% -50.49% 54.14%
Inventory
Prepaid Expenses $368.0K $428.8K $313.1K
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $48.79M $69.43M $20.90M
YoY Change -29.72% 134.19% 838.74%
LONG-TERM ASSETS
Property, Plant & Equipment $297.6K $92.06K $107.2K
YoY Change 223.3% -28.65% -28.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change
Total Long-Term Assets $810.7K $113.0K $128.2K
YoY Change 617.34% -24.65% -24.84%
TOTAL ASSETS
Total Short-Term Assets $48.79M $69.43M $20.90M
Total Long-Term Assets $810.7K $113.0K $128.2K
Total Assets $49.60M $69.54M $21.03M
YoY Change -28.67% 133.39% 777.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $511.2K $1.074M $1.277M
YoY Change -52.38% 37.25% 12.41%
Accrued Expenses $3.100M $1.900M $2.300M
YoY Change 63.16% 72.73%
Deferred Revenue $18.67M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.596M $21.63M $3.592M
YoY Change -83.38% 1065.01% -75.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $300.0K
YoY Change
Total Long-Term Liabilities $300.0K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.596M $21.63M $3.592M
Total Long-Term Liabilities $300.0K $0.00 $0.00
Total Liabilities $3.884M $21.60M $3.600M
YoY Change -82.02% 1036.84%
SHAREHOLDERS EQUITY
Retained Earnings -$133.1M -$122.0M -$108.6M
YoY Change 9.15% 24.88% 25.92%
Common Stock $178.9M $169.9M $126.0M
YoY Change 5.28% 35.24% 101611307.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $45.72M $47.91M $17.44M
YoY Change
Total Liabilities & Shareholders Equity $49.60M $69.54M $21.03M
YoY Change -28.67% 133.39% 777.29%

Cashflow Statement

Concept 2019 Q2 2018 Q2 2017 Q4
OPERATING ACTIVITIES
Net Income -$5.684M -$5.990M -$6.235M
YoY Change -5.11% 8.51% 77.23%
Depreciation, Depletion And Amortization $20.00K $10.00K $10.00K
YoY Change 100.0% -50.0% -50.0%
Cash From Operating Activities -$5.140M $13.11M -$4.610M
YoY Change -139.21% -307.44% 51.64%
INVESTING ACTIVITIES
Capital Expenditures $120.0K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $50.00K
YoY Change
Cash From Investing Activities -$120.0K $0.00 $50.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 41.91M 0.000
YoY Change -100.0% 104675.0% -100.0%
NET CHANGE
Cash From Operating Activities -5.140M 13.11M -4.610M
Cash From Investing Activities -120.0K 0.000 50.00K
Cash From Financing Activities 0.000 41.91M 0.000
Net Change In Cash -5.260M 55.02M -4.560M
YoY Change -109.56% -974.72% -1570.97%
FREE CASH FLOW
Cash From Operating Activities -$5.140M $13.11M -$4.610M
Capital Expenditures $120.0K $0.00 $0.00
Free Cash Flow -$5.260M $13.11M -$4.610M
YoY Change -140.12% -307.11% 51.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48157010
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62614010
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
368048
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
754392
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
264305
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
615681
CY2019Q2 us-gaap Assets Current
AssetsCurrent
48789363
CY2018Q4 us-gaap Assets Current
AssetsCurrent
63984083
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
297618
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
98449
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
472135
CY2019Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
40960
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
40960
CY2019Q2 us-gaap Assets
Assets
49600076
CY2018Q4 us-gaap Assets
Assets
64123492
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3402257
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5456917
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
193284
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3595541
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5456917
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
288055
CY2019Q2 us-gaap Liabilities
Liabilities
3883596
CY2018Q4 us-gaap Liabilities
Liabilities
5456917
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
4059
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
4059
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
178853870
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177621807
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133141449
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118959291
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
45716480
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
58666575
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49600076
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64123492
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40588004
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40588004
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40588004
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40588004
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1333333
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1333333
CY2018Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arpo:LicenseRevenueAndOtherMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arpo:LicenseRevenueAndOtherMember
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2264255
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4228934
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7850506
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2799570
CY2019Q2 us-gaap Restructuring Costs
RestructuringCosts
915094
us-gaap Restructuring Costs
RestructuringCosts
915094
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
7369788
us-gaap Operating Income Loss
OperatingIncomeLoss
-14820212
us-gaap Operating Income Loss
OperatingIncomeLoss
-13513103
CY2019Q2 arpo Grant Income
GrantIncome
4924
arpo Grant Income
GrantIncome
20272
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
290379
CY2018Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
46464
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
623499
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
295303
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
97580
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-5989991
us-gaap Net Income Loss
NetIncomeLoss
-14176441
us-gaap Net Income Loss
NetIncomeLoss
-13415523
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40588004
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27340914
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40588004
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27194028
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
621685
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-8492825
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
604661
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21992
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1079721
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-7425532
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
11111670
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1660
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
41905312
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
877757
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
47906408
CY2018Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3093489
us-gaap Depreciation
Depreciation
33503
us-gaap Depreciation
Depreciation
23665
us-gaap Share Based Compensation
ShareBasedCompensation
1226346
us-gaap Share Based Compensation
ShareBasedCompensation
1957478
arpo Increase Decrease In Prepaid Research And Development Contracts
IncreaseDecreaseInPrepaidResearchAndDevelopmentContracts
-386344
arpo Increase Decrease In Prepaid Research And Development Contracts
IncreaseDecreaseInPrepaidResearchAndDevelopmentContracts
115705
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-351376
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-108760
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2045456
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-626707
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
18666667
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14224328
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6598635
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
232672
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8498
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-232672
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8498
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23652
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
44998801
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3093489
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41928964
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14457000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
48519101
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20264109
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68783210
CY2018 arpo Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P3Y
arpo Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
2020-03-15
CY2018 arpo Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
2020-03-15
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results may differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls and in developing the estimates and assumptions used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: grant date fair value of the Company&#8217;s stock-based awards, accrued expenses, revenue recognition and income taxes. </p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s results can also be affected by economic, political, legislative, regulatory and legal actions.&nbsp;&nbsp;Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies, and changes in the prices of research studies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.</p>
us-gaap Intangible Assets Finite Lived Policy Costs Incurred To Renew Or Extend
IntangibleAssetsFiniteLivedPolicyCostsIncurredToRenewOrExtend
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Patents </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Costs incurred in connection with the application for and issuances of patents are expensed as incurred. </p>
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3351132
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4622428
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1201753
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6771807
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5183231
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk and Off-Balance Sheet Risk </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents are the only financial instruments that potentially subject the Company to concentrations of credit risk. At June&#160;30, 2019 and December&#160;31, 2018,&nbsp;&nbsp;the Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements. </p>
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0221
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0232
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6597
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6583
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1588576
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.80
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.62
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.37
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5683616
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 arpo Capital Stock Conversion Basis Ratio
CapitalStockConversionBasisRatio
2.3336572
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2018Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
511190
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
595680
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
264571
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
487923
CY2019Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
451644
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1877455
CY2019Q2 arpo Accrued Retention Bonus Current
AccruedRetentionBonusCurrent
157716
CY2019Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
88945
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
90663
CY2019Q2 arpo Accrued Project Costs Current
AccruedProjectCostsCurrent
1306752
CY2018Q4 arpo Accrued Project Costs Current
AccruedProjectCostsCurrent
2232014
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29612
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
173182
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
317562
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
317562
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.00
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.00
arpo Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P3Y
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.43
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M26D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y4M6D
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y4M13D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
142788
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17133
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
17133
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5956838
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
604661
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
877757
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.11
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M25D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M7D
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5989991
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14176441
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13415523
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
62085
us-gaap Operating Lease Cost
OperatingLeaseCost
124140
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
62154
us-gaap Operating Lease Payments
OperatingLeasePayments
124308
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M14D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1322
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
123354
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
239781
CY2019Q2 arpo Lessee Operating Lease Liability Payments Due Year Three And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearThreeAndThereafter
191685
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
554820
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
73481
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
481339
CY2018Q2 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
20000000

Files In Submission

Name View Source Status
0001564590-19-030747-index-headers.html Edgar Link pending
0001564590-19-030747-index.html Edgar Link pending
0001564590-19-030747.txt Edgar Link pending
0001564590-19-030747-xbrl.zip Edgar Link pending
arpo-10q_20190630.htm Edgar Link pending
arpo-20190630.xml Edgar Link completed
arpo-20190630.xsd Edgar Link pending
arpo-20190630_cal.xml Edgar Link unprocessable
arpo-20190630_def.xml Edgar Link unprocessable
arpo-20190630_lab.xml Edgar Link unprocessable
arpo-20190630_pre.xml Edgar Link unprocessable
arpo-ex311_7.htm Edgar Link pending
arpo-ex312_9.htm Edgar Link pending
arpo-ex321_8.htm Edgar Link pending
arpo-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending